‘Closed-loop’ AI clinical care is coming soon, startups predictnews2026-03-12T13:00:38+00:00March 12th, 2026|Endpoints News|
Generate:Biomedicines raises $400M IPO, CEO talks about AI’s future in drug designnews2026-02-27T16:38:54+00:00February 27th, 2026|Endpoints News|
Investors are pumping money into AI tools for health insurersnews2026-02-27T14:00:27+00:00February 27th, 2026|Endpoints News|
AI biotech Turbine raises $25M Series B to sell ‘Virtual Lab’ to pharmanews2026-02-24T12:00:54+00:00February 24th, 2026|Endpoints News|
Flagship’s Generate targets $2B+ valuation with Nasdaq IPOnews2026-02-23T16:27:28+00:00February 23rd, 2026|Endpoints News|
Why clinical AI startup Kintsugi shut downnews2026-02-18T20:43:12+00:00February 18th, 2026|Endpoints News|
Terray says its AI model beats Boltz-2 at binding affinity predictionnews2026-02-12T13:00:16+00:00February 12th, 2026|Endpoints News|
Leash Bio warns of ‘cheating’ AI models on drug-protein predictionsnews2026-02-12T12:00:17+00:00February 12th, 2026|Endpoints News|
Isomorphic claims major advance with new AI drug design enginenews2026-02-10T20:33:26+00:00February 10th, 2026|Endpoints News|
QuantX raises $85M Series B from Lilly, Sanofi Venturesnews2026-02-09T18:26:47+00:00February 9th, 2026|Endpoints News|
